{
    "eid": "2-s2.0-84946720638",
    "title": "Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients",
    "cover-date": "2015-11-01",
    "subject-areas": [
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [
        "HIV/ HBV coinfection",
        "Population pharmacokinetics",
        "Tenofovir"
    ],
    "authors": [
        "Baralee Punyawudho"
    ],
    "citedby-count": 7,
    "ref-count": 36,
    "ref-list": [
        "Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection",
        "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA Level",
        "Epidemiology of viral hepatitis and HIV co-infection",
        "Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men",
        "The influence of HTLV\u2010III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers",
        "Accelerated Loss of Antibody to Hepatitis B Surface Antigen among Immunodeficient Homosexual Men Infected with HIV",
        "HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)",
        "Tenofovir: A nucleotide analog for the management of human immunodeficiency virus infection",
        "Tenofovir disoproxil fumarate: Clinical pharmacology and pharmacokinetics",
        "Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, Tenofovir",
        "Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection",
        "Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome",
        "Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, fanconi syndrome, and nephrogenic diabetes insipidus",
        "Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-na\u00efve patients with HIV infection",
        "Long-term treatment with tenofovir: Prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration",
        "Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events",
        "Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations",
        "Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and Hepatitis B or C coinfected adults without symptoms of hepatic impairment",
        "Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients",
        "Population pharmacokinetics of tenofovir in AIDS patients",
        "Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy",
        "March",
        "Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy",
        "Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers",
        "Xpose - An S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM",
        "A new equivalence based metric for predictive check to qualify mixed-effects models",
        "Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check",
        "Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir",
        "The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients",
        "Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs",
        "HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter",
        "Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro",
        "Common clinical conditions-age, low BMI, ritonavir use, mild renal impairment-affect tenofovir pharmacokinetics in a large cohort of HIV-infected women",
        "Renal impairment in patients receiving a tenofovir-cART regimen: Impact of tenofovir trough concentration",
        "Considerations in Analyzing Single-Trough Concentrations Using Mixed-Effects Modeling",
        "Intracellular pharmacokinetics of antiretroviral drugs in HIV-infected patients, and their correlation with drug action"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kensington",
            "affilname": "The Kirby Institute",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "Monash University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "Burnet Institute",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Nijmegen",
            "affilname": "Radboud University Medical Center",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Chiang Mai University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}